Advocates, affected communities and their representatives are invited to take part in a short survey aiming to assess community participation in guidelines development.

GENEVA, 12 September 2022 – The Global Fund’s 2022 Results Report released today finds a significant rebound in 2021 for programs working to defeat HIV, tuberculosis (TB) and malaria. In 2020, the COVID-19 pandemic had a devastating impact on the fight against the three diseases, leading to the decline of key programmatic results across the three diseases for the first time in the history of the Global Fund. When the pandemic hit countries where the Global Fund works, the partnership rapidly mounted a response to deliver additional resources. This year, the new report shows those investments paid off and recovery is underway.

The Stop TB Partnership and Devex will host a virtual event on 22 September 2022 on the sidelines of the 77th Session of the United Nations General Assembly (UNGA 77) that will bring global health leaders together to focus on what’s needed to accelerate progress for ending TB by 2030.

WHO Director-General and WHO Civil Society Task Force on TB release a joint statement setting collective priorities in preparation for the 2023 UN High-Level Meeting on TB.

Public-private collaboration to evaluate five antimicrobial agents across two combination regimens for treating both drug-susceptible and drug-resistant forms of TB with shorter treatment durations.

The World Health Organization (WHO) will host a webinar on 6 September 2022 to present the updated Guidance for national strategic planning for TB, and share perspectives and experiences from countries, civil society and partners.

The World Health Organization (WHO) is releasing new guidance to support national strategic planning for the tuberculosis (TB) response. The guidance encourages the use of a people-centeric focus in the development of national TB strategic plan (NSP). It highlights the importance of government stewardship and ownership, promotes alignment with national health strategy and other health programmes, emphasizes multi stakeholder and multi-sectoral engagement as one of the key steps for multisectoral accountability for TB.

Curdlan is a popular carbohydrate in the food industry. Its name is derived from the word “curdle”, and as it suggests, it’s widely used as a thickener and stabiliser in everything from sausages to milk substitutes.

BOSTON, 15 August 2022 – Researchers at Massachusetts General Hospital (MGH), published a new paper in Cell Reports Medicine demonstrating the protective potential of multiple doses of the Bacillus Calmette-Guerin (BCG) vaccine against COVID-19 and other infectious diseases.

TB, HIV, and hepatitis C virus (HCV) share a global presence and propensity to disproportionately affect marginalized populations. However, over recent decades, many fewer drugs have been brought to market for TB than for the others.